Treatment of dermatomyositis with medium-dose glucocorticoid and high-dose intravenous immunoglobulin: two case report

Jie CHEN,Ai-ping ZHANG,Lin TANG,Zhi-li GUO,Ming YAN,Jun GU
DOI: https://doi.org/10.3969/j.issn.1000-4963.2005.04.039
2005-01-01
Abstract:Two patients with dermatomyositis complicated with hypertension, diabetes and duodenal ulcer were treated successfully with medium-dose glucocorticoid and high-dose intravenous immunoglobulin (HDIVIG). They both had elevated serum muscle enzymes. The dosage of immunoglobulin in one case was 300mg/kg/d for 5 days, the other 400mg/kg/d for 4 days. Muscle weakness relieved quickly and the serum muscle enzymes decreased to the normal level after above treatment. No obvious adverse effect was observed. It is suggested that HDIVIG might be one of the effective therapies for dermatomyositis.
What problem does this paper attempt to address?